Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer

NCT00667251 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

652

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: docetaxel
DRUG: lapatinib ditosylate
DRUG: paclitaxel

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]